生物科技公司Moderna(MRNA)今日盘前期股价大跌5%,引发市场广泛关注。
据报导,特朗普政府有意撤销对Moderna公司开发禽流感疫苗的5.9亿美元资助合同。这笔钜款原本是去年1月由美国政府授予Moderna,用于推进其mRNA技术禽流感疫苗研发。一旦撤资,将严重打击该公司在流感疫苗领域的布局,也将动摇市场对其长期发展前景的信心。
分析人士指出,这一举措或与新任卫生部长罗伯特·F·肯尼迪对新冠mRNA疫苗持怀疑态度有关,也是拜登政府审查mRNA疫苗支出的一部分。世界各国疫情好转,公众对疫苗需求下降,政府可能将把资金转向其他领域。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.